Latest AbbVie Stories
NORTH CHICAGO, Ill., March 19, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that it has entered into an exclusive worldwide license agreement with C(2)N Diagnostics, a privately
- 22 abstracts further evaluate the safety, efficacy of HUMIRA in psoriatic arthritis and moderate to severe chronic plaque psoriasis and investigational use of HUMIRA for the treatment of moderate
NORTH CHICAGO, Ill., March 6, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Barclays Global Health Care Conference on Thursday, March 12, 2015. Richard A.
Fifteen Accepted Abstracts Include New Data From: NORTH CHICAGO, Ill., Feb.
NORTH CHICAGO, Ill., Feb. 25, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Cowen 35(th) Annual Health Care Conference on Wednesday, March 4, 2015.
- In adult patients co-infected with genotype 1 (GT1) hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1), TURQUOISE-I, using VIEKIRA PAK with ribavirin (RBV), demonstrated sustained
- Submission based on Phase 3 GIFT-I study in patients with genotype 1b chronic hepatitis C virus infection NORTH CHICAGO, Ill., Feb.
NORTH CHICAGO, Ill., Jan. 16, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its fourth-quarter and full-year 2014 financial results on Friday, Jan.
-- DUOPA is the first and only treatment providing 16 continuous hours of carbidopa and levodopa for motor fluctuations in advanced Parkinson's disease NORTH CHICAGO, Ill., Jan.
- Expects Adjusted Earnings Per Share of $4.25 to $4.45 (GAAP EPS of $3.99 to $4.19); Guidance to be Further Refined as HCV Launch Progresses NORTH CHICAGO, Ill., Jan.
- Forsooth! indeed! originally a parenthetical phrase used in repeating the words of another with more or less contempt or disdain.